TY  - RPRT
TI  - Surrogate endpoints and FDA's accelerated approval process.
AU  - Thomas R Fleming
DO  - 10.1377/hlthaff.24.1.67
UR  - https://pubmed.ncbi.nlm.nih.gov/15647217/
ID  - 15647217
ER  -